INSACOG
(Redirected from
Indian SARS-CoV-2 Consortium on Genomics
)| Consortium overview | |
|---|---|
| Formed | December 30, 2020 |
| Type | Consortium under Government of India |
| Status | Active |
| Parent department | Department of Biotechnology |
| Website | dbtindia.gov.in/insacog |
INSACOG (Indian SARS-CoV-2 Consortium on GenomicsLineage B.1.1.7 earlier found in United Kingdom in December 2020.
INSACOG works as a consortium of 38
See also
References
- ^ a b "Genome Sequencing by INSACOG shows variants of concern and a Novel variant in India". Ministry of Health and Family Welfare. 24 March 2021. Retrieved 17 May 2021.
- ^ a b Das, Krishna N (16 May 2021). "Top Indian virologist quits government panel after airing differences". Reuters. Retrieved 17 May 2021.
- ^ Pulla, Priyanka (28 February 2021). "India's Genome Sequencing Program Is Finally Good To Go – So What's the Hold Up?". The Wire. Retrieved 17 May 2021.
- ^ "INSACOG | Department of Biotechnology". Government of India Ministry of Science & Technology. Retrieved 24 January 2022.
- ^ "INSACOG | Department of Biotechnology". Government of India Ministry of Science & Technology. Retrieved 28 September 2021.
- ^ Dey, Sushmi (29 December 2020). "10 labs to be regional hubs for genome sequencing". The Times of India. Retrieved 17 May 2021.
- ^ Koshy, Jacob (8 April 2021). "Coronavirus | Indian 'double mutant' strain named B.1.617". The Hindu. Retrieved 2021-04-19.
Though these mutations have individually been found in several other coronavirus variants, the presence of both these mutations together have been first found in some coronavirus genomes from India.
- ^ Ghoshal, Devjyot; Das, Krishna N (3 May 2021). "EXCLUSIVE Scientists say India government ignored warnings amid coronavirus surge". Reuters. Retrieved 17 May 2021.